Marker Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Marker Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Marker Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Marker Therapeutics Inc. is MRKR:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Marker Therapeutics Inc. has its primary listing on NASDAQ (Small cap). You can trade Marker Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Marker Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Marker Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Marker Therapeutics Inc..